FOXP2 and breast carcinoma: In line with the previously reported oncogenic mechanism (entity “breast cancer”), it might be necessary to determine whether the observed FOXP2 levels concern endogenous HCC cancer stem cells per se, or mesenchymal stem cells prone to HCC homing.